Regor Therapeutics Strikes Deal with Genentech for CDK Inhibitors, Fetching USD 850 Million Upfront
Regor Therapeutics Group, a US-based biotech with significant ties to China, has entered into a...
Regor Therapeutics
Zhangjiang AI New Drug R&D Alliance Expands with New Members
The Zhangjiang AI New Drug R&D Alliance has welcomed new participants, including Regor Therapeutics, Roche,...
Qilu Regor’s RGT-264 Phosphate Tablets Approved for Phase I Study
China-based biotech Qilu Regor Therapeutics Inc has announced receiving approval from the National Medical Products...